Stock BAI BENEVOLENTAI
Add to a list
To use this feature you must be a member
Log inSign up

All News BenevolentAI

Equities

BAI

LU2355630455

Market Closed - Euronext Amsterdam
Other stock markets
 11:19:25 2024-05-02 am EDT 		5-day change 1st Jan Change
0.64 EUR 0.00% Intraday chart for BenevolentAI -5.88% -40.74%
03:30pm Benevolentai S.A. Announces Directorate Changes CI
Apr. 15 BenevolentAI S.A. Announces Board Resignations, Effective from May 2, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BenevolentAI : Benevolent AI, - Result of Annual General Meeting
PU
BenevolentAI: Result of Annual General Meeting
BU
Benevolentai S.A. Announces Directorate Changes
CI
BenevolentAI : Major shareholding notifications Major shareholding notification
PU
BenevolentAI : Benevolent AI, - BenevolentAI provides an update on its business priorities
PU
BenevolentAI Provides an Update on Its Business Priorities
BU
BenevolentAI - Publication of the Revised Agenda for the 2024 AGM
AQ
BenevolentAI : Benevolent AI, - Publication of the Revised Agenda for the 2024 AGM
PU
BenevolentAI : Inside Information / Ad Hoc Information Publication of the Revised Agenda for the 2024 AGM
PU
BenevolentAI: Publication of the Revised Agenda for the 2024 AGM
BU
Proposed changes to BenevolentAI's Board composition
AQ
Proposed Changes to BenevolentAI’s Board Composition
BU
BenevolentAI S.A. Announces Board Resignations, Effective from May 2, 2024
CI
BenevolentAI Founder Reportedly Calls for Board Revamp
MT
BenevolentAI Founder Reportedly Calls for Board Revamp
MT
Kenneth Mulvany Sends a Letter to Benovelent AI
CI
EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises
AN
BenevolentAI : Inside Information / Ad Hoc Information BenevolentAI announces positive topline safety and pharmacokinetic data from the Phase Ia clinical study of BEN-8744 in healthy volunteers
PU
BenevolentAI Announces Positive Topline Safety and Pharmacokinetic Data from the Phase Ia Clinical Study of BEN-8744 in Healthy Volunteers
BU
BenevolentAI Announces Positive Topline Safety and Pharmacokinetic Data from the Phase Ia Clinical Study of BEN-8744 in Healthy Volunteers
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAI Stock
  4. News BenevolentAI